PERCENTAGE OF CHANGE IN CLINICAL OUTCOMES OF ALBUMIN-CGFSGEL AS AN ADJUNCT TO SCALING AND ROOT PLANING IN STAGE III PERIODONTITIS (RANDOMIZED CONTROLLED CLINICAL TRIAL)

Background: Periodontitis is a chronic inflammatory disease characterized by progressive destruction of the periodontal supporting tissues Although scaling and root planing (SRP) remains the gold standard for non-surgical periodontal therapy, complete elimination of periodontal pathogens could not always be achieved Therefore, adjunctive therapeutic modalities capable of enhancing periodontal wound healing have gained increasing attention. Albumin-based concentrated growth factors (Alb-CGFs) represents a modified platelet concentrate with prolonged structural stability and sustained release of biologically active molecules, which could enhance periodontal healing outcomes. Aim: Is to analyse the percentage of improvement in clinical parameters following adjunctive use of albumin based concentrated growth factorsin the non-surgical treatment of periodontitis patients.